STOCK TITAN

Hydreight Technologies Named One of the Americas’ Fastest Growing Companies by Financial Times

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Hydreight Technologies (OTCQB: HYDTF) has been named to the Financial Times list of The Americas' Fastest Growing Companies 2025, validating its remarkable growth trajectory in the digital health platform sector. The company has achieved a stunning 2,400% revenue growth from $400K to nearly $24M in just five years, while maintaining positive Adjusted EBITDA.

Ranked 56th on Deloitte's Technology Fast 500™ and 9th in Canada, Hydreight met strict criteria including: minimum revenue of $100,000 in 2020 and $1.5M in 2023, independent company status, and primarily organic growth. The company is expanding into high-growth sectors including:

  • GLP-1 weight-loss medications
  • Anti-aging therapies
  • IV wellness
  • At-home testing
  • Chronic care management

The company plans to launch new offerings, scale M&A, and expand its national footprint in 2025, positioning itself as a leader in direct-to-consumer telehealth services across the U.S.

Hydreight Technologies (OTCQB: HYDTF) è stata inserita nella lista del Financial Times delle aziende in più rapida crescita delle Americhe per il 2025, convalidando la sua straordinaria traiettoria di crescita nel settore delle piattaforme di salute digitale. L'azienda ha registrato una crescita dei ricavi straordinaria del 2.400%, passando da 400.000 dollari a quasi 24 milioni di dollari in soli cinque anni, mantenendo un EBITDA rettificato positivo.

Classificata al 56° posto nella lista Technology Fast 500™ di Deloitte e al 9° in Canada, Hydreight ha soddisfatto criteri rigorosi tra cui: ricavi minimi di 100.000 dollari nel 2020 e 1,5 milioni di dollari nel 2023, status di azienda indipendente e crescita principalmente organica. L'azienda si sta espandendo in settori ad alta crescita tra cui:

  • medicinali per la perdita di peso GLP-1
  • terapie anti-invecchiamento
  • benessere IV
  • test a domicilio
  • gestione della cura cronica

L'azienda prevede di lanciare nuove offerte, scalare fusioni e acquisizioni, e ampliare la sua presenza nazionale nel 2025, posizionandosi come leader nei servizi di telemedicina diretti ai consumatori negli Stati Uniti.

Hydreight Technologies (OTCQB: HYDTF) ha sido incluida en la lista del Financial Times de las empresas de más rápido crecimiento en las Américas para 2025, validando su notable trayectoria de crecimiento en el sector de plataformas de salud digital. La compañía ha logrado un impresionante crecimiento del 2,400% en ingresos, pasando de 400,000 dólares a casi 24 millones de dólares en solo cinco años, manteniendo un EBITDA ajustado positivo.

Clasificada en el puesto 56 en la lista Technology Fast 500™ de Deloitte y en el 9º en Canadá, Hydreight cumplió con criterios estrictos que incluyen: ingresos mínimos de 100,000 dólares en 2020 y 1.5 millones de dólares en 2023, estatus de empresa independiente y crecimiento principalmente orgánico. La compañía se está expandiendo a sectores de alto crecimiento que incluyen:

  • medicamentos para la pérdida de peso GLP-1
  • terapias anti-envejecimiento
  • bienestar IV
  • pruebas en casa
  • gestión de cuidados crónicos

La compañía planea lanzar nuevas ofertas, escalar fusiones y adquisiciones, y expandir su presencia nacional en 2025, posicionándose como líder en servicios de telemedicina directos al consumidor en los EE. UU.

Hydreight Technologies (OTCQB: HYDTF)는 2025년 아메리카의 가장 빠르게 성장하는 기업 목록에 Financial Times에 이름을 올리며 디지털 건강 플랫폼 분야에서의 놀라운 성장 궤적을 입증했습니다. 회사는 400,000달러에서 거의 2,400만 달러로 매출이 2,400% 증가하는 놀라운 성과를 달성했습니다, 단 5년 만에 긍정적인 조정 EBITDA를 유지하면서 말이죠.

Deloitte의 Technology Fast 500™에서 56위, 캐나다에서 9위로 선정된 Hydreight는 2020년에 최소 100,000달러, 2023년에 150만 달러의 최소 매출, 독립 기업 상태 및 주로 유기적 성장을 포함한 엄격한 기준을 충족했습니다. 이 회사는 고성장 분야로 확장하고 있습니다:

  • GLP-1 체중 감소 약물
  • 노화 방지 요법
  • IV 웰니스
  • 자가 검사
  • 만성 질환 관리

이 회사는 2025년에 새로운 제품을 출시하고, 인수합병을 확대하며, 미국 전역에서 소비자 직접 의료 서비스의 선두주자로 자리매김하기 위해 국가적 입지를 확장할 계획입니다.

Hydreight Technologies (OTCQB: HYDTF) a été nommée dans la liste du Financial Times des entreprises à la croissance la plus rapide des Amériques pour 2025, validant sa trajectoire de croissance remarquable dans le secteur des plateformes de santé numérique. L'entreprise a réalisé une croissance des revenus époustouflante de 2 400%, passant de 400 000 $ à près de 24 millions de dollars en seulement cinq ans, tout en maintenant un EBITDA ajusté positif.

Classée 56ème dans le classement Technology Fast 500™ de Deloitte et 9ème au Canada, Hydreight a satisfait à des critères stricts, notamment : un chiffre d'affaires minimum de 100 000 $ en 2020 et de 1,5 million $ en 2023, un statut d'entreprise indépendante et une croissance principalement organique. L'entreprise s'étend dans des secteurs à forte croissance tels que :

  • médicaments GLP-1 pour la perte de poids
  • thérapies anti-âge
  • bien-être IV
  • tests à domicile
  • gestion des soins chroniques

L'entreprise prévoit de lancer de nouvelles offres, d'accroître ses fusions et acquisitions et d'étendre sa présence nationale en 2025, se positionnant comme un leader dans les services de télémédecine destinés directement aux consommateurs aux États-Unis.

Hydreight Technologies (OTCQB: HYDTF) wurde in die Liste der am schnellsten wachsenden Unternehmen in Amerika 2025 des Financial Times aufgenommen, was den bemerkenswerten Wachstumskurs im Bereich digitaler Gesundheitsplattformen bestätigt. Das Unternehmen hat ein beeindruckendes Umsatzwachstum von 2.400% erzielt, von 400.000 auf nahezu 24 Millionen Dollar in nur fünf Jahren, während es ein positives bereinigtes EBITDA aufrechterhielt.

Auf Platz 56 der Deloitte Technology Fast 500™ und 9. in Kanada eingestuft, erfüllte Hydreight strenge Kriterien, darunter: Mindestumsatz von 100.000 Dollar im Jahr 2020 und 1,5 Millionen Dollar im Jahr 2023, Status als unabhängiges Unternehmen und hauptsächlich organisches Wachstum. Das Unternehmen expandiert in hochwachstumsstarke Sektoren, darunter:

  • GLP-1 Gewichtsreduktionsmedikamente
  • Anti-Aging-Therapien
  • IV-Wellness
  • Tests zu Hause
  • Management chronischer Erkrankungen

Das Unternehmen plant, neue Angebote einzuführen, Fusionen und Übernahmen auszubauen und seine nationale Präsenz im Jahr 2025 zu erweitern, um sich als führendes Unternehmen im Bereich der Telemedizin direkt an den Verbraucher in den USA zu positionieren.

Positive
  • None.
Negative
  • None.

VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., has been named to the Financial Times list of The Americas’ Fastest Growing Companies 2025. This prestigious award is presented by the Financial Times and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on April 2nd, 2025, and can be viewed on the FT.com website.

The Americas’ Fastest Growing Companies 2025 ranking identifies companies with the strongest revenue growth between the years 2020 and 2023. The creation of the ranking was based on the following criteria:

  • Revenue of at least US $100,000 generated in 2020
  • Revenue of at least US $1.5M generated in 2023
  • The company is independent (the company is not a subsidiary or branch office of any kind)
  • The company is headquartered in one of 20 American countries
  • Revenue growth was primarily organic between 2020 and 2023

This recognition further validates Hydreight’s strong performance and execution. In just five years, Hydreight has scaled revenue from $400K to nearly $24M—a 2,400% increase—while maintaining positive Adjusted EBITDA. Ranked 56th on Deloitte’s Technology Fast 500™ and 9th in Canada.

Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys.

The Company is expanding into high-growth sectors like GLP-1 weight-loss medications, anti-aging therapies, IV wellness, at-home testing, and chronic care management—positioning itself at the forefront of the direct-to-consumer telehealth movement. With plans to launch new offerings, scale M&A, and further expand its national footprint in 2025, Hydreight continues to build on its momentum and long-term value creation for investors.

“Being recognized by the Financial Times as one of the fastest-growing companies in the Americas is a tremendous honor and a reflection of the incredible work our team has done over the past few years,” said Shane Madden, CEO of Hydreight Technologies Inc. “This achievement reinforces the strength of our business model, the growing demand for direct-to-consumer healthcare, and our commitment to making healthcare more accessible, scalable, and patient-centered across the U.S.”

On behalf of the Board of Directors

Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.

Hydreight Technologies Inc Ranked Number 56 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Hydreight Technologies Recognized as a Top 50 TSX Venture Exchange Company

Hydreight Recognized by the Financial Times as One of the Americas’ Fastest Growing Companies in 2025

Contact
Email: ir@hydreight.com; Telephone: 1 (702) 970-8112

About Hydreight Technologies Inc.
Hydreight Technologies Inc is building one of the largest mobile clinic network in the United States. Its proprietary, fully integrated platform hosts a network of over 3000 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

About VSDHOne - Direct to Consumer Platform
Developed in partnership with Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6), Hydreight Technologies launched the VSDHOne (Read as VSDH-One) platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform will help all businesses to launch a direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s (semaglutide, tirzepatide), peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy (“TRT”), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months.

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, path to profitability, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “projecting”, “expect” or similar expressions and includes information regarding expectations for the Company's growth, Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.


FAQ

What is Hydreight Technologies' (HYDTF) revenue growth from 2020 to 2025?

Hydreight Technologies grew revenue by 2,400%, scaling from $400K to nearly $24M in five years while maintaining positive Adjusted EBITDA.

What ranking did HYDTF achieve in the Financial Times Americas' Fastest Growing Companies 2025?

Hydreight Technologies was named to the Financial Times Americas' Fastest Growing Companies 2025 list, while also ranking 56th on Deloitte's Technology Fast 500™ and 9th in Canada.

What are the key expansion areas for Hydreight Technologies (HYDTF) in 2025?

HYDTF is expanding into GLP-1 weight-loss medications, anti-aging therapies, IV wellness, at-home testing, and chronic care management sectors.

What were the minimum revenue requirements for the FT Americas' Fastest Growing Companies 2025 list?

Companies needed to generate minimum revenue of US $100,000 in 2020 and US $1.5M in 2023 to qualify for the list.

What are Hydreight Technologies' (HYDTF) strategic plans for 2025?

HYDTF plans to launch new offerings, scale M&A activities, and expand its national footprint across the U.S. in 2025.
Hydreight Tech

OTC:HYDTF

HYDTF Rankings

HYDTF Latest News

HYDTF Stock Data

134.37M
20.75M
57.76%
0.28%
Health Information Services
Healthcare
Link
United States
Las Vegas